Katherine Bennett

High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study

Robert Terkeltaub, Daniel E. Furst, Katherine Bennett et al. · Arthritis & Rheumatism · 2010 · 530 citations

Medicine, Pharmacology, Pharmacotherapy +16

Clozapine-associated diabetes

Elizabeth A. Koller, B Schneider, Katherine Bennett et al. · The American Journal of Medicine · 2001 · 253 citations

Gemcitabine Plus Cisplatin, an Active Regimen in Advanced Urothelial Cancer: A Phase II Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, Eric Winquist, Nevin Murray et al. · Journal of Clinical Oncology · 1999 · 230 citations

Medicine, Oncology, Pharmacology +16

Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8

B. Norris, Kathleen I. Pritchard, K. James et al. · Journal of Clinical Oncology · 2000 · 144 citations

Medicine, Oncology, Pharmacology +17

A first-in-human, phase I study of an oral hedgehog (HH) pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors.

Lillian L. Siu, K. Papadopoulos, Steven R. Alberts et al. · Journal of Clinical Oncology · 2010 · 62 citations

Medicine, Oncology, Pharmacology +14